Postprandial lipaemia in familial combined hyperlipidaemia

Area of Science:

• Lipid Metabolism
• Cardiovascular Disease
• Genetics

Background:

• Familial combined hyperlipidaemia (FCHL) is the most common inherited lipid disorder.
• FCHL is characterized by elevated triglycerides, low HDL-cholesterol, and high ApoB.
• It is a significant risk factor for premature atherosclerosis.

Purpose of the Study:

• To elucidate the molecular basis of VLDL overproduction in FCHL.
• To understand the role of non-esterified fatty acids (NEFA) in FCHL pathogenesis.
• To explore the mechanisms linking FCHL to atherosclerosis development.

Main Methods:

• Analysis of lipid metabolism pathways in FCHL patients.
• Investigation of hepatic VLDL production and fatty acid trapping.
• Study of postprandial lipemia and remnant lipoprotein clearance.

Main Results:

• Hepatic overproduction of VLDL is a key feature, partly linked to insulin resistance.
• Disturbed peripheral fatty acid trapping enhances hepatic NEFA flux.
• Delayed clearance of triglyceride-rich remnant lipoproteins contributes to atherosclerosis.

Conclusions:

• FCHL pathogenesis involves VLDL overproduction and impaired remnant catabolism.
• Accumulation of NEFA and remnant lipoproteins promotes endothelial dysfunction and inflammation.
• These processes initiate atherosclerotic lesion development in FCHL.